Skip to main content
SpringerLink
Log in

Attitudes of Potential Providers Towards Preconceptional Cystic Fibrosis Carrier Screening

  • Published:
Journal of Genetic Counseling

Abstract

To determine the attitudes of potential providers (general practitioners and Community Health Service workers) towards preconceptional cystic fibrosis (CF) carrier screening and to determine which factors are associated with a positive attitude. A survey was conducted among 200 general practitioners (GPs) and 134 Community Health Service (CHS) workers. Fifty-two percent of the eligible GPs participated and 84% of the CHS workers. Fifty-five percent of the GPs and 73% of the CHS workers had a positive attitude towards routinely offering CF carrier screening, and more than 80% were in favor of informing the target population about the possibility of having a CF carrier test. A positive attitude was associated with (a) high perceived severity of CF, (b) religion (nonreligious compared to Reformed), (c) low perceived barriers, and (d) high perceived test reliability. The care providers who are most likely to be involved in a preconceptional CF carrier screening program, i.e. GPs and CHS workers, generally have a positive attitude towards the implementation of such a program.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Axworthy, D., Brock, D. J., Bobrow, M., & Marteau, T. M. (1996). Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group. Lancet, 347, 1443-1446.

    Google Scholar 

  • Bekker, H., Denniss, G., Modell, M., Bobrow, M., & Marteau, T. (1994). The impact of population based screening for carriers of cystic fibrosis. J Med Genet, 31, 364-368.

    Google Scholar 

  • Bernhardt, B. A., Chase, G. A., Faden, R. R., Geller, G., Hofman, K. J., Tambor, E. S., et al. (1996). Educating patients about cystic fibrosis carrier screening in a primary care setting. Arch Fam Med, 5, 336-340.

    Google Scholar 

  • Bobadilla, J. L., Macek, M. Jr., Fine, J. P., & Farrell, P. M. (2002). Cystic fibrosis: A worldwide analysis of CFTR mutations—correlation with incidence data and application to screening. Hum Mutat, 19, 575-606.

    Google Scholar 

  • Boerma, W. G. W., Van der Zee, J., & Fleming, D. M. (1997). Service profiles of general practitioners in Europe. Br J Gen Pract, 47, 481-486.

    Google Scholar 

  • Boulton, M., Cummings, C., & Williamson, R. (1996). The views of general practitioners on community carrier screening for cystic fibrosis. Br J Gen Pract, 46, 299-301.

    Google Scholar 

  • CBS. (2001). Statistics Netherlands. Population statistics. Voorburg/Heerlen, the Netherlands. Available from: http://www.cbs.nl.

  • Clayton, E. W. (1999). Lessons (re)learned from cystic fibrosis carrier screening. J Gend Specif Med, 2, 21-24.

    Google Scholar 

  • De Walle, H. E., De Jong-van den Berg, L. T., & Cornel, M. C. (1999). Periconceptional folic acid intake in the northern Netherlands. Lancet, 353, 1187.

    Google Scholar 

  • Estivill, X., Bancells, C., & Ramos, C. (1997). Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat, 10, 135-154.

    Google Scholar 

  • EUROGAPP Project 1999–2000. (2000). Public and Professional Policy Committee (PPPC) Population genetic screening programmes: Proposed recommendations of the European Society of Human Genetics. Eur J Hum Genet, 8, 998-1000.

    Google Scholar 

  • Faden, R. R., Tambor, E. S., Chase, G. A., Geller, G., Hofman, K. J., & Holtzman, N. A. (1994). Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening. Am J Med Genet, 50, 1-11.

    Google Scholar 

  • Grody, W. W., Cutting, G. R., Klinger, K. W., Richards, C. S., Watson, M. S., & Desnick, R. J. (2001). Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med, 3, 149-154.

    Google Scholar 

  • Grol, R. (1997). Beliefs and evidence in changing clinical practice. BMJ, 315, 418-421.

    Google Scholar 

  • Health Council of the Netherlands. (2003). Public awareness about genetics. The Hague: Health Council of the Netherlands (Publication No. 2003/05).

  • Henneman, L., Poppelaars, F. A. M., & Ten Kate, L. P. (2002). Evaluation of cystic fibrosis carrier screening programs according to genetic screening criteria. Genet Med, 4, 241-249.

    Google Scholar 

  • Henneman, L., Bramsen, I., Van Kempen, L., Van Acker, M. B., Pals, G., Van der Horst, H. E., et al. (2003). Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genet, 6, 5-13.

    Google Scholar 

  • Kaner, E. F., Haighton, C. A., & McAvoy, B. R. (1998). So much post, so busy with practice—So, no time!: A telephone survey of general practitioners' reasons for not participating in postal questionnaire surveys. Br J Gen Pract, 48, 1067-1069.

    Google Scholar 

  • Key, C., Layton, D., & Shakir, S.A. (2002). Results of a postal survey of the reasons for nonresponse by doctors in a Prescription Event Monitoring study of drug safety. Pharmacoepidemiol Drug Saf, 11, 143-148.

    Google Scholar 

  • Loeben, G. L., Marteau, T. M., & Wilfond, B. S. (1998). Mixed messages: Presentation of information in cystic fibrosis-screening pamphlets. Am J Hum Genet, 63, 1181-1189.

    Google Scholar 

  • McCormick, J., Green, M. W., Mehta, G., Culross, F., & Mehta, A. (2002). Demographics of the UK cystic fibrosis population: implications for neonatal screening. Eur J Hum Genet, 10, 583 – 590.

    Google Scholar 

  • Mennie, M. E., Compton, M. E., Gilfillan, A., Liston, W. A., Pullen, I., Whyte, D. A., et al. (1993). Prenatal screening for cystic fibrosis: Psychological effects on carriers and their partners. J Med Genet, 30, 543-548.

    Google Scholar 

  • Mennie, M., Campbell, H., Liston, W. A., & Brock, D. J. H. (1998). Attitudes of general practitioners to screening for cystic fibrosis. J Med Screen, 5, 11-15.

    Google Scholar 

  • Modell, M., Wonke, B., Anionwu, E., Khan, M., Tai, S. S., Lloyd, M., et al. (1998). A multidisciplinary approach for improving services in primary care: Randomised controlled trial of screening for haemoglobin disorders. BMJ, 317, 788-791.

    Google Scholar 

  • NIH. (1999). Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis. Arch Intern Med, 159, 1529-1539.

    Google Scholar 

  • Nuffield Council on Bioethics. (1993). Genetic screening: ethical issues. London: Nuffield Council on Bioethics.

    Google Scholar 

  • Poppelaars, F. A. M., Van der Wal, G., Braspenning, J. C. C., Cornel, M. C., Henneman, L., Langendam, M. W., et al. (2003). Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: A focus group study. Public Health.

  • Rommens, J. M., Iannuzzi, M. C., Kerem, B., Drumm, M. L., Melmer, G., Dean, M., et al. (1989). Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science, 245, 1059-1065.

    Google Scholar 

  • Rowley, P. T., Loader, S., Levenkron, J. C., & Phelps, C. E. (1993). Cystic fibrosis carrier screening: Knowledge and attitudes of prenatal care providers. Am J Prev Med, 9, 261-266.

    Google Scholar 

  • Rowley, P. T., Loader, S., & Kaplan, R. M. (1998). Prenatal screening for cystic fibrosis carriers: An economic evaluation. Am J Hum Genet, 63, 1160-1174.

    Google Scholar 

  • Scheffer, H., Van den Ouweland, A. M. W., & Veeze, H. J. (2001). From gene to disease: From diminished chloride ion transport channels to cystic fibrosis [in Dutch]. Ned Tijdschr Geneeskd, 145, 686-687.

    Google Scholar 

  • Stronks, K., Ravelli, A. C., & Reijneveld, S. A. (2001). Immigrants in the Netherlands: Equal access for equal needs? J Epidemiol Commun Health, 55, 701-707.

    Google Scholar 

  • Ten Kate, L. P., Verheij, J. B. G. M., Wildhagen, M. F., Hilderink, H. B. M., Kooij, L., Verzijl, J. G., et al. (1996). Comparison of single-entry and double-entry two-step couple screening for cystic fibrosis carriers. Hum Heredity, 46, 20-25.

    Google Scholar 

  • Tambor, E. S., Bernhardt, B. A., Chase, G. A., Faden, R. R., Geller, G., Hofman, K. J., et al. (1994). Offering cystic fibrosis carrier screening to an HMO population: Factors associated with utilization. Am J Hum Genet, 55, 626-637.

    Google Scholar 

  • Watson, E. K., Mayall, E. S., Lamb, J., Chapple, J., & Williamson, R. (1992). Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet, 340, 217-220.

    Google Scholar 

  • Watson, E. K., Williamson, R., & Chapple, J. (1991). Attitudes to carrier screening for cystic fibrosis: A survey of health care professionals, relatives of sufferers and other members of the public. Br J Gen Pract, 41, 237-240.

    Google Scholar 

  • Wildhagen, M. F., Hilderink, H. B., Verzijl, J. G., Verheij, J. B. G. M., Kooij, L., Tijmstra, T., et al. (1998). Costs, effects, and savings of screening for cystic fibrosis gene carriers. J Epidemiol Commun Health, 52, 459-467.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Genetics and Human Genetics, VU University Medical Center, Amsterdam, The Netherlands

    Francis A. M. Poppelaars, Martina C. Cornel, Lidewij Henneman & Leo P. ten Kate

  2. Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands

    Herman J. Adèr

  3. Department of Social Medicine, VU University Medical Center, Amsterdam, The Netherlands

    Lidewij Henneman & Gerrit van der Wal

  4. Centre for Quality of Care Research (WOK), University of Nijmegen, The Netherlands

    Rosella P. M. G. Hermens

Authors
  1. Francis A. M. Poppelaars
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Herman J. Adèr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martina C. Cornel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lidewij Henneman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rosella P. M. G. Hermens
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gerrit van der Wal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Leo P. ten Kate
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leo P. ten Kate.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poppelaars, F.A.M., Adèr, H.J., Cornel, M.C. et al. Attitudes of Potential Providers Towards Preconceptional Cystic Fibrosis Carrier Screening. Journal of Genetic Counseling 13, 31–44 (2004). https://doi.org/10.1023/B:JOGC.0000013193.80539.d1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:JOGC.0000013193.80539.d1

Search

Navigation